USFDA conducts GMP inspection at SMS Pharmaceuticals’ Vizianagaram facility

20 Jan 2020 Evaluate

United States Food and Drug Administration (USFDA) conducted a CGMP inspection at SMS Pharmaceuticals’ Kandivalasa, Vizianagaram, Andhra Pradesh API manufacturing facility from January 13, 2020 to January 17, 2020. The inspection ended with two observations which are procedural in nature and correctable.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities.

SMS Pharmaceuticals Share Price

375.70 -6.10 (-1.60%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×